GEN and GSK Related Headlines

Go Back

GEN and GSK Related Press Releases

Go Back

Apr 17, 2014 05:24PM GSK and Genmab receive FDA approval for Arzerra® (ofatumumab) as first-line treatment in combination with chlorambucil for patients with Chronic Lymphocytic Leukaemia (CLL) for whom fludarabine-based

GEN and GSK Related SEC Filings

Go Back